Jump to content

Brain-derived neurotrophic factor

From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Jgalvin2015 (talk | contribs) at 15:44, 7 December 2014. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Template:PBB Brain-derived neurotrophic factor, also known as BDNF, is a protein[1] that, in humans, is encoded by the BDNF gene.[2][3] BDNF is a member of the neurotrophin family of growth factors, which are related to the canonical Nerve Growth Factor. Neurotrophic factors are found in the brain and the periphery.

Function

BDNF acts on certain neurons of the central nervous system and the peripheral nervous system, helping to support the survival of existing neurons, and encourage the growth and differentiation of new neurons and synapses.[4][5] In the brain, it is active in the hippocampus, cortex, and basal forebrain—areas vital to learning, memory, and higher thinking.[6] It is also expressed in the retina, motor neurons, the kidneys, saliva, and the prostate.[7]

BDNF itself is important for long-term memory.[8] Although the vast majority of neurons in the mammalian brain are formed prenatally, parts of the adult brain retain the ability to grow new neurons from neural stem cells in a process known as neurogenesis. Neurotrophins are chemicals that help to stimulate and control neurogenesis, BDNF being one of the most active.[9][10][11] Mice born without the ability to make BDNF suffer developmental defects in the brain and sensory nervous system, and usually die soon after birth, suggesting that BDNF plays an important role in normal neural development.[12] Other important neurotrophins structurally related to BDNF include NT-3, NT-4, and NGF.

BDNF is made in the endoplasmic reticulum and secreted from dense-core vesicles. It binds carboxypeptidase E (CPE), and the disruption of this binding has been proposed to cause the loss of sorting of BDNF into dense-core vesicles. The phenotype for BDNF knockout mice can be severe, including postnatal lethality. Other traits include sensory neuron losses that affect coordination, balance, hearing, taste, and breathing. Knockout mice also exhibit cerebellar abnormalities and an increase in the number of sympathetic neurons.[13]

Exercise has been shown to increase the secretion of BDNF at the mRNA and protein levels in the rodent hippocampus, suggesting the potential increase of this neurotrophin after exercise in humans.[14]

Caffeine improves recognition memory, and this effect may be related to an increase of the BDNF and TrkB immunocontent in the hippocampus. [15]

Mechanism of Action

BDNF binds at least two receptors on the surface of cells that are capable of responding to this growth factor, TrkB (pronounced "Track B") and the LNGFR (for low-affinity nerve growth factor receptor, also known as p75).[16] It may also modulate the activity of various neurotransmitter receptors, including the Alpha-7 nicotinic receptor.[17] BDNF has also been shown to interact with the reelin signaling chain.[18] The expression of reelin by Cajal-Retzius cells goes down during development under the influence of BDNF.[19] The latter also decreases reelin expression in neuronal culture.

TrkB

The TrkB receptor is encoded by the NTRK2 gene and is member of a receptor family of tyrosine kinases that includes TrkA and TrkC. These receptors all interact with neurotrophins in a ligand-specific manner. TrkB autophosphorylation is dependent upon its ligand-specific association with BDNF, a widely expressed activity-dependent neurotrophic factor that regulates neuroplasticity and is upregulated following hypoxic injury.

LNGFR

The role of the other BDNF receptor, p75, is less clear role. While the TrkB receptor interacts with BDNF in a ligand-specific manner, all neurotrophins can interact with the p75 receptor [20] . When the p75 receptor is activated, it leads to activation of NFkB receptor [21]. Thus, neurotrophic signaling may trigger apoptosis rather than survival pathways in cells expressing the p75 receptor in the absence of Trk receptors. Recent studies have revealed a truncated isoform of the TrkB receptor (t-TrkB) may act as a dominant negative to the p75 neurotrophin receptor, inhibiting the activity of p75, and preventing BDNF-mediated cell death. [22]

BDNF is Expressed in an Activity-Dependent Manner

The BDNF protein is encoded by a gene that is also called BDNF, found in humans on chromosome 11 [2][3]. Structurally, BDNF transcription is controlled by 8 different promoters, each leading to different transcripts containing one of the 8 untranslated 5’ promoter exons spliced to the 3’ encoding exon. Promoter IV activity is strongly stimulated by calcium and is primarily under the control of a Cre regulatory component, suggesting a putative role for the transcription factor CREB and the source of BDNF’s activity-dependent effects . [23] There are multiple mechanisms through neuronal activity can increase BDNF exon IV specific expression [24]. Stimulus-mediated neuronal excitation can lead to NMDA receptor activation, triggering a calcium influx. Through a protein signaling cascade requiring Erk, CaM KII/IV, PI3K, and PLC, NMDA receptor activation is capable of triggering BDNF exon IV transcription. BDNF exon IV expression is also seems capable of further stimulating its own expression through TrkB activation. BDNF is released from the post-synaptic membrane in an activity-dependent manner, allowing it to act on local TrkB receptors and mediate effects that can leading to signaling cascades also involving Erk and CaM KII/IV. [25][26]. Both of these pathways probably involve calcium-mediated phosphorylation of CREB at Ser133, thus allowing it to interact with BDNF’s Cre regulatory domain and upregulate transcription. [27] However, NMDA-mediated receptor signaling is probably necessary to trigger the upregulation of BDNF exon IV expression because normally CREB interaction with CRE and the subsequent translation of the BDNF transcript is blocked by of the basic helix-loop-helix transcription factor protein 2 (BHLHB2). [28] NMDA receptor activation triggers the release of the regulatory inhibitor, allowing for BDNF exon IV upregulation to take place in response to the activity-initiated calcium influx. [29] Activation of Dopamine receptor D5 also promotes expression of BDNF in prefrontal cortex neurons.[30]

Val66Met (rs6265) is a single nucleotide polymorphism in the gene where adenine and guanine alleles vary, resulting in a variation between valine and methionine at codon 66.[31][32] As of 2008, Val66Met is probably the most investigated SNP of the BDNF gene, but, besides this variant, other SNPs in the gene are C270T, rs7103411, rs2030324, rs2203877, rs2049045 and rs7124442.

Role in Synaptic Transmission

BDNF Enhances Glutamatergic Signaling

Glutamate is the brain’s major excitatory neurotransmitter and its release can trigger the depolarization of postsynaptic neurons. AMPA and NMDA receptors are two major ionotrophic receptors that are especially suspected of being involved in learning and memory. While AMPA receptor activation leads to depolarization via sodium influx, NMDA receptor activation leads to depolarization via calcium and sodium influx. The calcium influx triggered through NMDA receptors can lead to the activity-dependent expression of many different genes, proteins, and receptors that are thought to be involved in processes involving learning, memory, neurogenesis, and environmental responses. The activity-dependent synaptic responses also lead to rapid insertion of AMPA receptors into the postsynaptic membrane, which will act to maintain ongoing glutamatergic transmission as sustained calcium influx could result in excitotoxicity

Elevations in BDNF Increase NMDA Receptor Activity

NMDA receptor activation is essential to producing the activity-dependent molecular changes involved in the formation of new memories. Following exposure to an enriched environment, BDNF and NR1 phosphorylation levels are upregulated simultaneously, probably because BDNF is capable of phosphorylating NR1 subunits, in addition to its many other effects. [33] [34] [35]. One of the primary ways BDNF can modulate NMDA receptor activity is through phosphorylation and activation of the NMDA receptor one subunit, particularly at the PKC Ser-897 site. [36] The mechanism underlying this activity is dependent upon both ERK and PKC signaling pathways, each acting individually, and all NR1 phosphorylation activity is lost if the TrKB receptor is blocked. [37] PI3 kinase and Akt are also essential in BDNF-induced potentiation of NMDA receptor function and inhibition of either molecule completely eliminated receptor activity. [38] BDNF can also increase NMDA receptor activity through phosphorylation of the NR2B subunit. BDNF signaling leads to the autophosphorylation of the intracellular domain of the TrkB receptor (ICD-TrkB). Upon autophosphorylation, Fyn associates with the pICD-TrkB through it’s Src homology domain 2 (SH2) and is phosphorylated at its Y416 site [39] [40]. Once activated, Fyn can bind to NR2B through it’s SH2 domain and mediate phosphorylation of its Tyr-1472 site [41]. Similar studies have suggested Fyn is also capable of activating NR2A although this was not found in the hippocampus [42] [43]. Thus, BDNF can increase NMDA receptor activity through Fyn activation. This has been shown to be important for processes such as spatial memory in the hippocampus, demonstrating the therapeutic and functional relevance of BDNF-mediated NMDA receptor activation [44].

BDNF Maintains Synapse Stability through AMPA Receptors

In addition to mediating transient effects on NMDAR activation to promote memory-related molecular changes, BDNF should also initiate more stable effects that could be maintained in its absence and not depend on its expression for long term synaptic support [45]. It was previously mentioned that AMPA receptor expression is essential to learning and memory formation, as these are the components of the synapse that will communicate regularly and maintain the synapse structure and function long after the initial activation of NMDA channels. BDNF is capable of increasing the mRNA expression of GluR1 and GluR2 through its interaction with the TrkB receptor and promoting the synaptic localization of GluR1 via PKC- and CaMKII-mediated Ser-831 phosphorylation. [46] It also appears that BDNF is able to influence [[Gl1 activity through its effects on NMDA receptor activity [47]. BDNF significantly enhanced the activation of GluR1 through phosphorylation of tyrosine830, an effect that was abolished in either the presence of a specific NR2B antagonist or a trk receptor tyrosine kinase inhibitor [48]. Thus, it appears BDNF can upregulate the expression and synaptic localization of AMPA receptors, as well as enhance their activity through its postsynaptic interactions with the NR2B subunit. This suggests BDNF is not only capable of initiating synapse formation through its effects on NMDA receptor activity, but it can also support the regular every-day signaling necessary for stable memory function.

BDNF Prevents GABAergic Signaling

One mechanism through which BDNF appears to maintain elevated levels of neuronal excitation is through preventing GABAergic signaling activities [49].. While glutamate is the brain’s major excitatory neurotransmitter and phosphorylation normally activates receptors, GABA is the brain’s primary inhibitory neurotransmitter and phoshorylation of GABAA receptors tend to reduce their activity. Blockading BDNF signaling with a tyrosine kinase inhibitor or a PKC inhibitor in wild type mice produced significant reductions in spontaneous action potential frequencies that were mediated by an increase in the amplitude of GABAergic inhibitory postsynaptic currents (IPSC) [50]. Similar effects could be obtained in BDNF knockout mice, but these effects were reversed by local application of BDNF [51]. This suggests BDNF increases excitatory synaptic signaling partly through the post-synaptic suppression of GABAergic of signaling by activating PKC through its association with TrkB (Henneberger et al., 2002). Once activated, PKC can reduce the amplitude of IPSCs through to GABAA receptor phosphorylation and inhibition [52]. In support of this putative mechanism, activation of PKCε leads to phophorylation of N-ethylmaleimide-sensitive factor (NSF) at serine 460 and threonine 461, increasing its ATPase activity which downregulates GABAA receptor surface expression and subsequently attenuates inhibitory currents [53].

Synaptogenesis

BDNF is also enhances synaptogenesis. Synaptogenesis is dependent upon the assembly of new synapses and the disassembly of old synapses by B-adducin [54]. Adducins are membrane-skeletal proteins that cap the growing ends of actin filaments and promote their association with spectrin, another cytoskeletal protein, to create stable and integrated cytoskeletal networks. [55] Actins have a variety of roles in synaptic functioning. In pre-synaptic neurons, actins are involved in synaptic vesicle recruitment and vesicle recovery following neurotransmitter release [56]. In post-synaptic neurons they can influence dendritic spine formation and retraction as well as AMPA receptor insertion and removal [57]. At their C-terminus, adducins possess a myristoylated alanine-rich C kinase substrate (MARCKS) domain which regulates their capping activity [58]. BDNF can reduce capping activities by upregulating PKC, which can bind to the adducing MRCKS domain, inhibit capping activity, and promote synatogenesis through dendritic spine growth and disassembly and other activities [59]. [60].

Dendridogenesis

Local interaction of BDNF with the TrkB receptor on a single dendritic segment is able to stimulate an increase in PSD-95 trafficking to other separate dendrites as well as to the synapses of locally stimulated neurons. [61] PSD-95 localizes the actin-remodeling GTPases, Rac and Rho, to synapses through the binding of its PDZ domain to kalirin, increasing the number and size of spines. [62] Thus, BDNF-induced trafficking of PSD-95 to dendrites stimulates actin remodeling and causes dendritic growth in response to BDNF.

Neurogenesis

BDNF plays a significant role in neurogenesis. BDNF can promote protective pathways and inhibit damaging pathways in the NSCs and NPCS that contribute to the brain’s neurogenic response by enhancing cell survival. This becomes especially evident following suppression of TrkB activity [63]. TrkB inhibition results in a 2-3 fold increase in cortical precursors displaying EGFP-positive condensed apoptotic nuclei and a 2-4 fold increase in cortical precursors that stained immunopositive for cleaved caspase-3 [64]. . BDNF can also promote NSC and NPC proliferation through Akt activation and PTEN inactivation. [65]. There have been many in vivo studies demonstrating BDNF is a strong promoter of neuronal differentiation. [66] [67]. Infusion of BDNF into the lateral ventricles doubled the population of newborn neurons in the adult rat olfactory bulb and viral overexpression of BDNF can similarly enhance SVZ neurogenesis . [68] [69] [70] BDNF might also play a role in NSC/NPC migration. By stabilizing p35, in utero electroporation studies revealed BDNF was able to promote cortical radial migration by about 2.3-fold in embryonic rats, an effect which was dependent on the activity of the trkB receptor. [71]

Environmental Enrichment Improves Cognitive Function Through Upregulation of BDNF

Enriched housing provides the opportunity for exercise and exposure to multimodal stimuli. The increased visual, physical, and cognitive stimulation all translates into more neuronal activity and synaptic communication, which can produce structural or molecular activity-dependent alterations [72] [73]. Sensory inputs from environmental stimuli are initially processed by the cortex before being transmitted to the hippocampus along an afferent pathway, suggesting the activity-mediated effects of enrichment can be far-reaching within the brain [74] BDNF expression is significantly enhanced by environmental enrichment and appears to be the primary source of environmental enrichments ability to enhance cognitive processes. Environmental enrichment enhances synaptogenesis, dendridogenesis, and neurogenesis, leading to improved performance on various learning and memory tasks. BDNF mediates more pathways involved in these enrichment-induced processes than any other molecule and is strongly regulated by calcium activity making it incredibly sensitive to neuronal activity.

Disease linkage

See also: Neuroplasticity and Medulla oblongata

Various studies have shown possible links between BDNF and conditions, such as depression,[75][76] schizophrenia,[77] obsessive-compulsive disorder,[78] Alzheimer's disease,[79] Huntington's disease,[80] Rett syndrome,[81] and dementia,[82] as well as anorexia nervosa[83] and bulimia nervosa.[84] Increased levels of BDNF can induce a change to an opiate-dependent-like reward state when expressed in the ventral tegmental area in rats.[85]

Schizophrenia

A plethora of recent evidence suggests the linkage between schizophrenia and BDNF [86]. Given that BDNF is critical for the survival of central nervous system (CNS) and peripheral nervous system (PNS) neurons and synaptogenesis during and even after development, BDNF alterations may play a role in the pathogenesis of schizophrenia. BDNF has been found within many areas of the brain and plays an important role is supporting the formation of memories [87]. It has been shown that BDNF mRNA levels are decreased in cortical layers IV and V of the dorsolateral prefrontal cortex of schizophrenic patients, an area that is known to be involved with working memory [88]. Since schizophrenic patients often suffer from impairments in working memory, and BDNF mRNA levels have been shown to be decreased in the DLPFC of schizophrenic patients, it is highly likely that BDNF plays some role in the etiology of this neurodevelopmental disorder of the CNS.

Depression

Exposure to stress and the stress hormone corticosterone has been shown to decrease the expression of BDNF in rats, and, if exposure is persistent, this leads to an eventual atrophy of the hippocampus. Atrophy of the hippocampus and other limbic structures has been shown to take place in humans suffering from chronic depression.[89] In addition, rats bred to be heterozygous for BDNF, therefore reducing its expression, have been observed to exhibit similar hippocampal atrophy. This suggests that an etiological link between the development of depression and BDNF exists. Supporting this, the excitatory neurotransmitter glutamate, voluntary exercise,[90] caloric restriction, intellectual stimulation, curcumin[91] and various treatments for depression (such as antidepressants[92] and electroconvulsive therapy[93] and sleep deprivation[94]) increase expression of BDNF in the brain. In the case of some treatments such as drugs[95] and electroconvulsive therapy[96] this has been shown to protect or reverse this atrophy.[95]

Eczema

High levels of BDNF and Substance P have been found associated with increased itching in eczema.[97]

Epilepsy

Epilepsy has also been linked with polymorphisms in BDNF. Given BDNF's vital role in the development of the landscape of the brain, there is quite a lot of room for influence on the development of neuropathologies from BDNF. Levels of both BDNF mRNA and BDNF protein are known to be up-regulated in epilepsy.[98] BDNF modulates excitatory and inhibitory synaptic transmission by inhibiting GABAA-receptor-mediated post-synaptic currents.[99] This provides a potential mechanism for the observed up-regulation.

Alzheimer's disease

Post mortem analysis has shown lowered levels of BDNF in the brain tissues of people with Alzheimer's disease, although the nature of the connection remains unclear. Studies suggest that neurotrophic factors have a protective role against amyloid beta toxicity.[100]

Drug Addiction

BDNF is a critical regulator of drug dependency. Animals chronically exposed to drugs of abuse show increased levels of BDNF in the ventral tegmental area (VTA) of the brain, and when BDNF is injected directly into the VTA of rats, the animals act as if they are dependent on opiates.[101]

Obesity

In 2009, variants close to the BDNF gene were found to be associated with obesity in two very large genome wide-association studies of body mass index (BMI).[102][103]

Cengenital Central Hypoventilation Syndrome

The polymorphism Thr2Ile may be linked to congenital central hypoventilation syndrome.[104][105]

References

  1. ^ Binder DK, Scharfman HE (2004). "Brain-derived Neurotrophic Factor". Growth Factors. 22 (3): 123–31. doi:10.1080/08977190410001723308. PMC 2504526. PMID 15518235. {{cite journal}}: Unknown parameter |month= ignored (help)
  2. ^ a b Jones KR, Reichardt LF (1990). "Molecular cloning of a human gene that is a member of the nerve growth factor family". Proc. Natl. Acad. Sci. U.S.A. 87 (20): 8060–4. doi:10.1073/pnas.87.20.8060. PMC 54892. PMID 2236018. {{cite journal}}: Unknown parameter |month= ignored (help)
  3. ^ a b Maisonpierre PC; Le Beau MM; Espinosa R; et al. (1991). "Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations". Genomics. 10 (3): 558–68. doi:10.1016/0888-7543(91)90436-I. PMID 1889806. {{cite journal}}: Unknown parameter |author-separator= ignored (help); Unknown parameter |month= ignored (help)
  4. ^ Acheson A, Conover JC, Fandl JP, DeChiara TM, Russell M, Thadani A, Squinto SP, Yancopoulos GD, Lindsay RM (1995). "A BDNF autocrine loop in adult sensory neurons prevents cell death". Nature. 374 (6521): 450–3. doi:10.1038/374450a0. PMID 7700353. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  5. ^ Huang EJ, Reichardt LF (2001). "Neurotrophins: Roles in Neuronal Development and Function". Annu. Rev. Neurosci. 24: 677–736. doi:10.1146/annurev.neuro.24.1.677. PMC 2758233. PMID 11520916.
  6. ^ Yamada K, Nabeshima T (2003). "Brain-derived neurotrophic factor/TrkB signaling in memory processes". J. Pharmacol. Sci. 91 (4): 267–70. doi:10.1254/jphs.91.267. PMID 12719654. {{cite journal}}: Unknown parameter |month= ignored (help)
  7. ^ Mandel AL, Ozdener H, Utermohlen V (2009). "Identification of Pro- and Mature Brain-derived Neurotrophic Factor in Human Saliva". Arch. Oral Biol. 54 (7): 689–95. doi:10.1016/j.archoralbio.2009.04.005. PMC 2716651. PMID 19467646. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  8. ^ Bekinschtein P, Cammarota M, Katche C, Slipczuk L, Rossato JI, Goldin A, Izquierdo I, Medina JH (2008). "BDNF is essential to promote persistence of long-term memory storage". Proc. Natl. Acad. Sci. U.S.A. 105 (7): 2711–6. doi:10.1073/pnas.0711863105. PMC 2268201. PMID 18263738. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  9. ^ Zigova T, Pencea V, Wiegand SJ, Luskin MB (1998). "Intraventricular administration of BDNF increases the number of newly generated neurons in the adult olfactory bulb". Mol. Cell. Neurosci. 11 (4): 234–45. doi:10.1006/mcne.1998.0684. PMID 9675054. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  10. ^ Benraiss A, Chmielnicki E, Lerner K, Roh D, Goldman SA (1 September 2001). "Adenoviral brain-derived neurotrophic factor induces both neostriatal and olfactory neuronal recruitment from endogenous progenitor cells in the adult forebrain". J. Neurosci. 21 (17): 6718–31. PMID 11517261.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  11. ^ Pencea V, Bingaman KD, Wiegand SJ, Luskin MB (1 September 2001). "Infusion of brain-derived neurotrophic factor into the lateral ventricle of the adult rat leads to new neurons in the parenchyma of the striatum, septum, thalamus, and hypothalamus". J. Neurosci. 21 (17): 6706–17. PMID 11517260.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  12. ^ Ernfors P, Kucera J, Lee KF, Loring J, Jaenisch R (1995). "Studies on the physiological role of brain-derived neurotrophic factor and neurotrophin-3 in knockout mice". Int. J. Dev. Biol. 39 (5): 799–807. PMID 8645564. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  13. ^ MGI database: phenotypes for BDNF homozygous null mice. http://www.informatics.jax.org/searches/allele_report.cgi?_Marker_key=537&int:_Set_key=847156
  14. ^ Cotman CW, Berchtold NC (2002). "Exercise: a behavioral intervention to enhance brain health and plasticity". Trends Neurosci. 25 (6): 295–301. doi:10.1016/S0166-2236(02)02143-4. PMID 12086747. {{cite journal}}: Unknown parameter |month= ignored (help)
  15. ^ http://www.ncbi.nlm.nih.gov/pubmed/18620014
  16. ^ Patapoutian A, Reichardt LF (2001). "Trk receptors: mediators of neurotrophin action". Curr. Opin. Neurobiol. 11 (3): 272–80. doi:10.1016/S0959-4388(00)00208-7. PMID 11399424. {{cite journal}}: Unknown parameter |month= ignored (help)
  17. ^ Fernandes CC, Pinto-Duarte A, Ribeiro JA, Sebastião AM (2008). "Postsynaptic action of brain-derived neurotrophic factor attenuates alpha7 nicotinic acetylcholine receptor-mediated responses in hippocampal interneurons". J. Neurosci. 28 (21): 5611–8. doi:10.1523/JNEUROSCI.5378-07.2008. PMID 18495895. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  18. ^ Fatemi, S. Hossein (2008). Reelin Glycoprotein: Structure, Biology and Roles in Health and Disease. Berlin: Springer. pp. 444 pages. ISBN 978-0-387-76760-4.; see the chapter "A Tale of Two Genes: Reelin and BDNF"; pp. 237-245
  19. ^ Ringstedt T, Linnarsson S, Wagner J, Lendahl U, Kokaia Z, Arenas E, Ernfors P, Ibáñez CF (1998). "BDNF regulates reelin expression and Cajal-Retzius cell development in the cerebral cortex". Neuron. 21 (2): 305–15. doi:10.1016/S0896-6273(00)80540-1. PMID 9728912. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  20. ^ Bartkowska K, Paquin A, Gauthier AS, Kaplan DR, Miller FD. Trk signaling regulates neural precursor cell proliferation and differentiation during cortical development. Development. 2007 Dec; 134 (24) :4369-80. PubMed PMID:18003743.
  21. ^ Bartkowska K, Paquin A, Gauthier AS, Kaplan DR, Miller FD. Trk signaling regulates neural precursor cell proliferation and differentiation during cortical development. Development. 2007 Dec; 134 (24) :4369-80. PubMed PMID:18003743.
  22. ^ Michaelsen K, Zagrebelsky M, Berndt-Huch J, Polack M, Buschler A, Sendtner M, Korte M. Neurotrophin receptors TrkBT1 and p75NTR cooperate in modulating both functional and structural plasticity in mature hippocampal neurons. Eur J Neurosci. 2010 Dec; 32 (11) :1854-65. PubMed PMID:20955473.
  23. ^ Zheng F, Wang H. NMDA-mediated and self-induced bdnf exon IV transcriptions are differentially regulated in cultured cortical neurons. Neurochem Int. 2009 May-Jun; 54 (5-6) :385-92. PubMed PMID:19418634; PubMed Central PMCID: PMC2722960.
  24. ^ Zheng F, Wang H. NMDA-mediated and self-induced bdnf exon IV transcriptions are differentially regulated in cultured cortical neurons. Neurochem Int. 2009 May-Jun; 54 (5-6) :385-92. PubMed PMID:19418634; PubMed Central PMCID: PMC2722960.
  25. ^ Kuzumaki N, Ikegami D, Tamura R, Hareyama N, Imai S, Narita M, Torigoe K, Niikura K, Takeshima H, Ando T, Igarashi K, Kanno J, Ushijima T, Suzuki T, Narita M. Hippocampal epigenetic modification at the brain-derived neurotrophic factor gene induced by an enriched environment. Hippocampus. 2011 Feb; 21 (2) :127-32. PubMed PMID:20232397
  26. ^ Zheng F, Wang H. NMDA-mediated and self-induced bdnf exon IV transcriptions are differentially regulated in cultured cortical neurons. Neurochem Int. 2009 May-Jun; 54 (5-6) :385-92. PubMed PMID:19418634; PubMed Central PMCID: PMC2722960.
  27. ^ Tao X, Finkbeiner S, Arnold DB, Shaywitz AJ, Greenberg ME. Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron. 1998 Apr; 20 (4) :709-26. PubMed PMID:9581763.
  28. ^ Jiang X, Tian F, Du Y, Copeland NG, Jenkins NA, Tessarollo L, Wu X, Pan H, Hu XZ, Xu K, Kenney H, Egan SE, Turley H, Harris AL, Marini AM, Lipsky RH. BHLHB2 controls Bdnf promoter 4 activity and neuronal excitability. J Neurosci. 2008 Jan 30; 28 (5) :1118-30. PubMed PMID:18234890.
  29. ^ Jiang X, Tian F, Du Y, Copeland NG, Jenkins NA, Tessarollo L, Wu X, Pan H, Hu XZ, Xu K, Kenney H, Egan SE, Turley H, Harris AL, Marini AM, Lipsky RH. BHLHB2 controls Bdnf promoter 4 activity and neuronal excitability. J Neurosci. 2008 Jan 30; 28 (5) :1118-30. PubMed PMID:18234890.
  30. ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 22827965, please use {{cite journal}} with |pmid=22827965 instead.
  31. ^ Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, Lu B, Weinberger DR (2003). "The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function". Cell. 112 (2): 257–69. doi:10.1016/S0092-8674(03)00035-7. PMID 12553913. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  32. ^ Bath KG, Lee FS (2006). "Variant BDNF (Val66Met) impact on brain structure and function". Cogn Affect Behav Neurosci. 6 (1): 79–85. doi:10.3758/CABN.6.1.79. PMID 16869232. {{cite journal}}: Unknown parameter |month= ignored (help)
  33. ^ Slack SE, Pezet S, McMahon SB, Thompson SW, Malcangio M. Brain-derived neurotrophic factor induces NMDA receptor subunit one phosphorylation via ERK and PKC in the rat spinal cord. Eur J Neurosci. 2004 Oct; 20 (7) :1769-78. PubMed PMID:15379998.
  34. ^ Sánchez-Pérez AM, Llansola M, Felipo V. Modulation of NMDA receptors by AKT kinase. Neurochem Int. 2006 Sep; 49 (4) :351-8. PubMed PMID:16621159.
  35. ^ Xu X, Ye L, Ruan Q. Environmental enrichment induces synaptic structural modification after transient focal cerebral ischemia in rats. Exp Biol Med (Maywood). 2009 Mar; 234 (3) :296-305. PubMed PMID:19244205.
  36. ^ Slack SE, Pezet S, McMahon SB, Thompson SW, Malcangio M. Brain-derived neurotrophic factor induces NMDA receptor subunit one phosphorylation via ERK and PKC in the rat spinal cord. Eur J Neurosci. 2004 Oct; 20 (7) :1769-78. PubMed PMID:15379998.
  37. ^ Slack SE, Pezet S, McMahon SB, Thompson SW, Malcangio M. Brain-derived neurotrophic factor induces NMDA receptor subunit one phosphorylation via ERK and PKC in the rat spinal cord. Eur J Neurosci. 2004 Oct; 20 (7) :1769-78. PubMed PMID:15379998.
  38. ^ Sánchez-Pérez AM, Llansola M, Felipo V. Modulation of NMDA receptors by AKT kinase. Neurochem Int. 2006 Sep; 49 (4) :351-8. PubMed PMID:16621159.
  39. ^ Namekata K, Harada C, Taya C, Guo X, Kimura H, Parada LF, Harada T. Dock3 induces axonal outgrowth by stimulating membrane recruitment of the WAVE complex. Proc Natl Acad Sci U S A. 2010 Apr 20; 107 (16) :7586-91. PubMed PMID:20368433; PubMed Central PMCID: PMC2867726.
  40. ^ Iwasaki Y, Gay B, Wada K, Koizumi S. Association of the Src family tyrosine kinase Fyn with TrkB. J Neurochem. 1998 Jul; 71 (1) :106-11. PubMed PMID:9648856.
  41. ^ Nakazawa T, Komai S, Tezuka T, Hisatsune C, Umemori H, Semba K, Mishina M, Manabe T, Yamamoto T. Characterization of Fyn-mediated tyrosine phosphorylation sites on GluR epsilon 2 (NR2B) subunit of the N-methyl-D-aspartate receptor. J Biol Chem. 2001 Jan 5; 276 (1) :693-9. PubMed PMID:11024032.
  42. ^ Mizuno M, Yamada K, He J, Nakajima A, Nabeshima T. Involvement of BDNF receptor TrkB in spatial memory formation. Learn Mem. 2003 Mar-Apr; 10 (2) :108-15. PubMed PMID:12663749; PubMed Central PMCID: PMC196664.
  43. ^ Tezuka T, Umemori H, Akiyama T, Nakanishi S, Yamamoto T. PSD-95 promotes Fyn-mediated tyrosine phosphorylation of the N-methyl-D-aspartate receptor subunit NR2A. Proc Natl Acad Sci U S A. 1999 Jan 19; 96 (2) :435-40. PubMed PMID:9892651; PubMed Central PMCID: PMC15154.
  44. ^ Mizuno M, Yamada K, He J, Nakajima A, Nabeshima T. Involvement of BDNF receptor TrkB in spatial memory formation. Learn Mem. 2003 Mar-Apr; 10 (2) :108-15. PubMed PMID:12663749; PubMed Central PMCID: PMC196664.
  45. ^ Briones TL, Suh E, Jozsa L, Hattar H, Chai J, Wadowska M. Behaviorally-induced ultrastructural plasticity in the hippocampal region after cerebral ischemia. Brain Res. 2004 Feb 6; 997 (2) :137-46. PubMed PMID:14706865.
  46. ^ Caldeira MV, Melo CV, Pereira DB, Carvalho R, Correia SS, Backos DS, Carvalho AL, Esteban JA, Duarte CB. Brain-derived neurotrophic factor regulates the expression and synaptic delivery of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor subunits in hippocampal neurons. J Biol Chem. 2007 Apr 27; 282 (17) :12619-28. PubMed PMID:17337442.
  47. ^ Wu K, Len GW, McAuliffe G, Ma C, Tai JP, Xu F, Black IB. Brain-derived neurotrophic factor acutely enhances tyrosine phosphorylation of the AMPA receptor subunit GluR1 via NMDA receptor-dependent mechanisms. Brain Res Mol Brain Res. 2004 Nov 4; 130 (1-2) :178-86. PubMed PMID:15519688.
  48. ^ Wu K, Len GW, McAuliffe G, Ma C, Tai JP, Xu F, Black IB. Brain-derived neurotrophic factor acutely enhances tyrosine phosphorylation of the AMPA receptor subunit GluR1 via NMDA receptor-dependent mechanisms. Brain Res Mol Brain Res. 2004 Nov 4; 130 (1-2) :178-86. PubMed PMID:15519688.
  49. ^ Henneberger C, Jüttner R, Rothe T, Grantyn R. Postsynaptic action of BDNF on GABAergic synaptic transmission in the superficial layers of the mouse superior colliculus. J Neurophysiol. 2002 Aug; 88 (2) :595-603. PubMed PMID:12163512.
  50. ^ Henneberger C, Jüttner R, Rothe T, Grantyn R. Postsynaptic action of BDNF on GABAergic synaptic transmission in the superficial layers of the mouse superior colliculus. J Neurophysiol. 2002 Aug; 88 (2) :595-603. PubMed PMID:12163512.
  51. ^ Henneberger C, Jüttner R, Rothe T, Grantyn R. Postsynaptic action of BDNF on GABAergic synaptic transmission in the superficial layers of the mouse superior colliculus. J Neurophysiol. 2002 Aug; 88 (2) :595-603. PubMed PMID:12163512.
  52. ^ Henneberger C, Jüttner R, Rothe T, Grantyn R. Postsynaptic action of BDNF on GABAergic synaptic transmission in the superficial layers of the mouse superior colliculus. J Neurophysiol. 2002 Aug; 88 (2) :595-603. PubMed PMID:12163512.
  53. ^ Chou WH, Wang D, McMahon T, Qi ZH, Song M, Zhang C, Shokat KM, Messing RO. GABAA receptor trafficking is regulated by protein kinase C(epsilon) and the N-ethylmaleimide-sensitive factor. J Neurosci. 2010 Oct 20; 30 (42) :13955-65. PubMed PMID:20962217; PubMed Central PMCID: PMC2994917.
  54. ^ Bednarek E, Caroni P. β-Adducin is required for stable assembly of new synapses and improved memory upon environmental enrichment. Neuron. 2011 Mar 24; 69 (6) :1132-46. PubMed PMID:21435558.
  55. ^ Matsuoka Y, Li X, Bennett V. Adducin: structure, function and regulation. Cell Mol Life Sci. 2000 Jun; 57 (6) :884-95. PubMed PMID:10950304.
  56. ^ Stevens RJ, Littleton JT. Synaptic growth: dancing with adducin. Curr Biol. 2011 May 24; 21 (10) :R402-5. PubMed PMID:21601803.
  57. ^ Stevens RJ, Littleton JT. Synaptic growth: dancing with adducin. Curr Biol. 2011 May 24; 21 (10) :R402-5. PubMed PMID:21601803.
  58. ^ Matsuoka Y, Li X, Bennett V. Adducin: structure, function and regulation. Cell Mol Life Sci. 2000 Jun; 57 (6) :884-95. PubMed PMID:10950304.
  59. ^ Bednarek E, Caroni P. β-Adducin is required for stable assembly of new synapses and improved memory upon environmental enrichment. Neuron. 2011 Mar 24; 69 (6) :1132-46. PubMed PMID:21435558.
  60. ^ Stevens RJ, Littleton JT. Synaptic growth: dancing with adducin. Curr Biol. 2011 May 24; 21 (10) :R402-5. PubMed PMID:21601803.
  61. ^ Yoshii A, Constantine-Paton M. BDNF induces transport of PSD-95 to dendrites through PI3K-AKT signaling after NMDA receptor activation. Nat Neurosci. 2007 Jun; 10 (6) :702-11. PubMed PMID:17515902.
  62. ^ Penzes P, Johnson RC, Sattler R, Zhang X, Huganir RL, Kambampati V, Mains RE, Eipper BA. The neuronal Rho-GEF Kalirin-7 interacts with PDZ domain-containing proteins and regulates dendritic morphogenesis. Neuron. 2001 Jan; 29 (1) :229-42. PubMed PMID:11182094.
  63. ^ Bartkowska K, Paquin A, Gauthier AS, Kaplan DR, Miller FD. Trk signaling regulates neural precursor cell proliferation and differentiation during cortical development. Development. 2007 Dec; 134 (24) :4369-80. PubMed PMID:18003743.
  64. ^ Bartkowska K, Paquin A, Gauthier AS, Kaplan DR, Miller FD. Trk signaling regulates neural precursor cell proliferation and differentiation during cortical development. Development. 2007 Dec; 134 (24) :4369-80. PubMed PMID:18003743.
  65. ^ Tamura M, Gu J, Danen EH, Takino T, Miyamoto S, Yamada KM. PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway. J Biol Chem. 1999 Jul 16;274(29):20693-703. PubMed PMID: 10400703
  66. ^ Bath KG, Akins MR, Lee FS. BDNF control of adult SVZ neurogenesis. Dev Psychobiol. 2011 Mar 22; PubMed PMID:21432850; PubMed Central PMCID: PMC3139728.
  67. ^ Bartkowska K, Paquin A, Gauthier AS, Kaplan DR, Miller FD. Trk signaling regulates neural precursor cell proliferation and differentiation during cortical development. Development. 2007 Dec; 134 (24) :4369-80. PubMed PMID:18003743.
  68. ^ Bath KG, Akins MR, Lee FS. BDNF control of adult SVZ neurogenesis. Dev Psychobiol. 2011 Mar 22; PubMed PMID:21432850; PubMed Central PMCID: PMC3139728.
  69. ^ Benraiss A, Chmielnicki E, Lerner K, Roh D, Goldman SA. Adenoviral brain-derived neurotrophic factor induces both neostriatal and olfactory neuronal recruitment from endogenous progenitor cells in the adult forebrain. J Neurosci. 2001 Sep 1; 21 (17) :6718-31. PubMed PMID:11517261.
  70. ^ Zigova T, Pencea V, Wiegand SJ, Luskin MB. Intraventricular administration of BDNF increases the number of newly generated neurons in the adult olfactory bulb. Mol Cell Neurosci. 1998 Jul; 11 (4) :234-45. PubMed PMID:9675054.
  71. ^ Zhao CT, Li K, Li JT, Zheng W, Liang XJ, Geng AQ, Li N, Yuan XB. PKCdelta regulates cortical radial migration by stabilizing the Cdk5 activator p35. Proc Natl Acad Sci U S A. 2009 Dec 15; 106 (50) :21353-8. PubMed PMID:19965374; PubMed Central PMCID: PMC2781735.
  72. ^ van Praag H, Kempermann G, Gage FH. Neural consequences of environmental enrichment. Nat Rev Neurosci. 2000 Dec; 1 (3) :191-8. PubMed PMID:11257907.
  73. ^ Zhong L, Yan CH, Lu CQ, Xu J, Huang H, Shen XM. Calmodulin activation is required for the enhancement of hippocampal neurogenesis following environmental enrichment. Neurol Res. 2009 Sep; 31 (7) :707-13. PubMed PMID:19055875.
  74. ^ Zhong L, Yan CH, Lu CQ, Xu J, Huang H, Shen XM. Calmodulin activation is required for the enhancement of hippocampal neurogenesis following environmental enrichment. Neurol Res. 2009 Sep; 31 (7) :707-13. PubMed PMID:19055875.
  75. ^ Dwivedi Y (2009). "Brain-derived neurotrophic factor: role in depression and suicide". Neuropsychiatr Dis Treat. 5: 433–49. PMC 2732010. PMID 19721723.
  76. ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1017/S1461145708009309, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with |doi=10.1017/S1461145708009309 instead.
  77. ^ Xiu MH, Hui L, Dang YF, De Hou T, Zhang CX, Zheng YL, Chen DC, Kosten TR, Zhang XY (2009). "Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics". Prog. Neuropsychopharmacol. Biol. Psychiatry. 33 (8): 1508–12. doi:10.1016/j.pnpbp.2009.08.011. PMID 19720106. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  78. ^ Maina G, Rosso G, Zanardini R, Bogetto F, Gennarelli M, Bocchio-Chiavetto L (2009). "Serum levels of brain-derived neurotrophic factor in drug-na?ve obsessive-compulsive patients: A case-control study". J Affect Disord. 122 (1–2): 174–8. doi:10.1016/j.jad.2009.07.009. PMID 19664825. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  79. ^ Zuccato C, Cattaneo E (2009). "Brain-derived neurotrophic factor in neurodegenerative diseases". Nat Rev Neurol. 5 (6): 311–22. doi:10.1038/nrneurol.2009.54. PMID 19498435. {{cite journal}}: Unknown parameter |month= ignored (help)
  80. ^ Zajac MS, Pang TY, Wong N, Weinrich B, Leang LS, Craig JM, Saffery R, Hannan AJ (2009). "Wheel running and environmental enrichment differentially modify exon-specific BDNF expression in the hippocampus of wild-type and pre-motor symptomatic male and female Huntington's disease mice". Hippocampus. 20 (5): 621–36. doi:10.1002/hipo.20658. PMID 19499586. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  81. ^ Zeev BB, Bebbington A, Ho G, Leonard H, de Klerk N, Gak E, Vecsler M, Vecksler M, Christodoulou J (2009). "The common BDNF polymorphism may be a modifier of disease severity in Rett syndrome". Neurology. 72 (14): 1242–7. doi:10.1212/01.wnl.0000345664.72220.6a. PMC 2677489. PMID 19349604. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  82. ^ Arancio O, Chao MV (2007). "Neurotrophins, synaptic plasticity and dementia". Curr. Opin. Neurobiol. 17 (3): 325–30. doi:10.1016/j.conb.2007.03.013. PMID 17419049. {{cite journal}}: Unknown parameter |month= ignored (help)
  83. ^ Mercader JM, Fernández-Aranda F, Gratacòs M, Ribasés M, Badía A, Villarejo C, Solano R, González JR, Vallejo J, Estivill X (2007). "Blood levels of brain-derived neurotrophic factor correlate with several psychopathological symptoms in anorexia nervosa patients". Neuropsychobiology. 56 (4): 185–90. doi:10.1159/000120623. PMID 18337636.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  84. ^ Kaplan AS, Levitan RD, Yilmaz Z, Davis C, Tharmalingam S, Kennedy JL (2008). "A DRD4/BDNF gene-gene interaction associated with maximum BMI in women with bulimia nervosa". Int J Eat Disord. 41 (1): 22–8. doi:10.1002/eat.20474. PMID 17922530. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  85. ^ Varga-Perez H; Ting-A Kee R; Walton C; et al. (2009). "Ventral Tegmental Area BDNF Induces an Opiate-Dependent–Like Reward State in Naïve Rats". Science. 324 (5935): 1732–34. doi:10.1126/science.1168501. PMC 2913611. PMID 19478142. {{cite journal}}: Unknown parameter |author-separator= ignored (help); Unknown parameter |month= ignored (help)
  86. ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 25191916, please use {{cite journal}} with |pmid= 25191916 instead.
  87. ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 18263738, please use {{cite journal}} with |pmid= 18263738 instead.
  88. ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 24802307, please use {{cite journal}} with |pmid= 24802307 instead.
  89. ^ Warner-Schmidt JL, Duman RS (2006). "Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment". Hippocampus. 16 (3): 239–49. doi:10.1002/hipo.20156. PMID 16425236.
  90. ^ Russo-Neustadt AA, Beard RC, Huang YM, Cotman CW (2000). "Physical activity, and antidepressant treatment potentiate the expression of specific brain-derived neurotrophic factor transcripts in the rat hippocampus". Neuroscience. 101 (2): 305–12. doi:10.1016/S0306-4522(00)00349-3. PMID 11074154.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  91. ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 17022948, please use {{cite journal}} with |pmid=17022948 instead.
  92. ^ Shimizu, E; Hashimoto, K; Okamura, N; Koike, K; Komatsu, N; Kumakiri, C; Nakazato, M; Watanabe, H; Shinoda, N; et al. (2003). "Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants". Biol Psychiatry. 54 (1): 70–5. doi:10.1016/S0006-3223(03)00181-1. PMID 12842310. {{cite journal}}: Explicit use of et al. in: |first9= (help); Invalid |display-authors=9 (help)
  93. ^ Okamoto, T; Yoshimura, R; Ikenouchi-Sugita, A; Hori, H; Umene-Nakano, W; Inoue, Y; Ueda, N; Nakamura, J. (2008). "Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: a pilot study". Prog Neuropsychopharmacol Biol Psychiatry. 32 (5): 1185–90. doi:10.1016/j.pnpbp.2008.02.009. PMID 18403081. {{cite journal}}: Cite has empty unknown parameter: |author-name-separator= (help); Unknown parameter |author-separator= ignored (help)
  94. ^ Gorgulu, Y; Caliyurt, O (2009). "Rapid antidepressant effects of sleep deprivation therapy correlates with serum BDNF changes in major depression". Brain research bulletin. 80 (3): 158–62. doi:10.1016/j.brainresbull.2009.06.016. PMID 19576267. {{cite journal}}: Cite has empty unknown parameter: |author-name-separator= (help); Unknown parameter |author-separator= ignored (help); Unknown parameter |month= ignored (help)
  95. ^ a b Drzyzga, ŁUkasz R.; Marcinowska, A; Obuchowicz, E (2009). "Antiapoptotic and neurotrophic effects of antidepressants: a review of clinical and experimental studies". Brain research bulletin. 79 (5): 248–57. doi:10.1016/j.brainresbull.2009.03.009. PMID 19480984. {{cite journal}}: Cite has empty unknown parameter: |author-name-separator= (help); Unknown parameter |author-separator= ignored (help); Unknown parameter |month= ignored (help)
  96. ^ Taylor, SM (2008). "Electroconvulsive therapy, brain-derived neurotrophic factor, and possible neurorestorative benefit of the clinical application of electroconvulsive therapy". The journal of ECT. 24 (2): 160–5. doi:10.1097/YCT.0b013e3181571ad0. PMID 18580563. {{cite journal}}: Cite has empty unknown parameter: |author-name-separator= (help); Unknown parameter |author-separator= ignored (help); Unknown parameter |month= ignored (help)
  97. ^ "'Blood chemicals link' to eczema". BBC News. 2007-08-26.
  98. ^ Gall C, Lauterborn J, Bundman M, Murray K, Isackson P (1991). "Seizures and the regulation of neurotrophic factor and neuropeptide gene expression in brain". Epilepsy Res Suppl. 4: 225–45. PMID 1815605.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  99. ^ Tanaka T, Saito H, Matsuki N (1 May 1997). "Inhibition of GABAA synaptic responses by brain-derived neurotrophic factor (BDNF) in rat hippocampus". J Neurosci. 17 (9): 2959–66. PMID 9096132.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  100. ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 19076369, please use {{cite journal}} with |pmid=19076369 instead.
  101. ^ Hector Vargas-Perez, Ryan Ting-A-Kee, Christine H. Walton, D. Micah Hansen, Rozita Razavi, Laura Clarke, Mary Rose Bufalino, David W. Allison, Scott C. Steffensen, Derek van der Kooy (2009). "Ventral Tegmental Area BDNF Induces an Opiate-Dependent–Like Reward State in Naïve Rats". Science. doi:10.1126/science.1168501. PMID 2913611.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  102. ^ Thorleifsson G; Walters GB; Gudbjartsson DF; et al. (2009). "Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity". Nat. Genet. 41 (1): 18–24. doi:10.1038/ng.274. PMID 19079260. {{cite journal}}: Unknown parameter |author-separator= ignored (help); Unknown parameter |month= ignored (help)
  103. ^ Willer CJ; Speliotes EK; Loos RJ; et al. (2009). "Six new loci associated with body mass index highlight a neuronal influence on body weight regulation". Nat. Genet. 41 (1): 24–34. doi:10.1038/ng.287. PMC 2695662. PMID 19079261. {{cite journal}}: Unknown parameter |author-separator= ignored (help); Unknown parameter |month= ignored (help)
  104. ^ Omim - Brain-Derived Neurotrophic Factor; Bdnf
  105. ^ Weese-Mayer DE, Bolk S, Silvestri JM, Chakravarti A (2002). "Idiopathic congenital central hypoventilation syndrome: evaluation of brain-derived neurotrophic factor genomic DNA sequence variation". Am. J. Med. Genet. 107 (4): 306–310. doi:10.1002/ajmg.10133. PMID 11840487.{{cite journal}}: CS1 maint: multiple names: authors list (link)


Template:PBB Controls

Retrieved from "https://en.wikipedia.org/w/index.php?title=Brain-derived_neurotrophic_factor&oldid=637031415"